Development of a mosaic mRNA vaccine with AI-designed immunogens: A paradigm shift in vaccine science

Abad P, Coronado M, Vincelle-Nieto Á, Pérez-Benavente S, Fobil JN, Puyet A, Diez A, Reyes-Palomares A, Azcárate IG, Bautista JM. 2024. Shotgun characterization of the circulating IgM antigenome of an infectious pathogen by immunocapture-LC–MS/MS from dried serum spots. Journal of Proteome Research 23(2), 633–643.

Abdaal K, Batool A, Navid MT, Ahmed S, Qazi AS, Safdar W, Ali H, Rashid M, Rafaqat S. 2024. Advancements in vaccination strategies: From historical milestones to modern innovations in viral disease prevention and public health. Research Journal of Veterinary Practice 12(1), 11–21.

Aleem MT, Munir F, Shakoor A, Gao F. 2024. mRNA vaccines against infectious diseases and future direction. International Immunopharmacology 135, 112320.

Ali R, Qazi S, Jaiswal M, Gurung N, Sharma S, Panat L, Yenishetti S, Priya V, Sharma A. 2025. Applications of AI in cancer genomics: A way toward intelligent decision systems in healthcare. Deep Learning in Genetics and Genomics, 293–307.

Ali U, Ali MT, Ali MT. 2024. Synergies of AI and smart technology: Transforming cancer medicine, vaccine development, and patient care. International Journal of Multidisciplinary Research and Growth Evaluation.

Alum EU, Uti DE, Ugwu OP, Alum BN. 2024. Toward a cure – Advancing HIV/AIDS treatment modalities beyond antiretroviral therapy: A review. Medicine 103(27), e38768.

Alzahrani A. 2024. Research developments and understandings in the dynamics of COVID-19: A comprehensive review. International Journal of Pharmaceutical Investigation 14(4).

Bai Z, Wan D, Lan T, Hong W, Dong H, Wei Y, Wei X. 2024. Nanoplatform-based intranasal vaccines: Current progress and clinical challenges. ACS Nano 18(36), 24650–24681.

Bhaskar S, Reddy N, Ramamurthy SS. 2025. Future perspectives and research directions: Technological advances and novel applications of nanostructures. Nano-Engineering at Functional Interfaces for Multi-Disciplinary Applications, 581–600.

Boniolo F, Dorigatti E, Ohnmacht AJ, Saur D, Schubert B, Menden MP. 2021. Artificial intelligence in early drug discovery enabling precision medicine. Expert Opinion on Drug Discovery 16(9), 991–1007.

Bravi B. 2024. Development and use of machine learning algorithms in vaccine target selection. npj Vaccines 9(1), 15.

Buckland B, Sanyal G, Ranheim T, Pollard D, Searles JA, Behrens S, Pluschkell S, Josefsberg J, Roberts CJ. 2024. Vaccine process technology—A decade of progress. Biotechnology and Bioengineering.

Chaudhary N, Weissman D, Whitehead KA. 2021. mRNA vaccines for infectious diseases: Principles, delivery and clinical translation. Nature Reviews Drug Discovery 20(11), 817–838.

Chentoufi AA, Ulmer JB, BenMohamed L. 2024. Antigen delivery platforms for next-generation coronavirus vaccines. Vaccines 13(1), 30.

Danda RR, Dileep V. 2024. Leveraging AI and machine learning for enhanced preventive care and chronic disease management in health insurance plans. Frontiers in Health Informatics 13(3), 6878–6891.

Dokhale S, Garse S, Devarajan S, Thakur V, Kolhapure S. 2025. Rational design of antiviral therapeutics. Computational Methods for Rational Drug Design, 423–443.

Edalat F, Tabatabaie FH, Moattari A, Letafati A, Sarvari J, Hosseini SY. 2024. Delving into revolutionary SARS-CoV-2 vaccine approaches: Molecular and virological examinations; principles of SARS-CoV-2 vaccine platform. Vacunas (English Edition) 25(1), 109–127.

Exposito JY, Monge C, Arruda DC, Verrier B. 2025. Immune responses to mRNA vaccine. Trends in mRNA Vaccine Research, 29–68.

Fang E, Liu X, Li M, Zhang Z, Song L, Zhu B, Wu X, Liu J, Zhao D, Li Y. 2022. Advances in COVID-19 mRNA vaccine development. Signal Transduction and Targeted Therapy 7(1), 94.

Fernandes Q, Inchakalody VP, Merhi M, Mestiri S, Taib N, Moustafa Abo El-Ella D, Bedhiafi T, Raza A, Al-Zaidan L, Mohsen MO, Yousuf Al-Nesf MA. 2022. Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines. Annals of Medicine 54(1), 524–540.

Gao Y, Yang L, Li Z, Peng X, Li H. 2024. mRNA vaccines in tumor targeted therapy: Mechanism, clinical application, and development trends. Biomarker Research 12(1), 93.

Grewal S, Hegde N, Yanow SK. 2024. Integrating machine learning to advance epitope mapping. Frontiers in Immunology 15, 1463931.

Gupta A, Rudra A, Reed K, Langer R, Anderson DG. 2024. Advanced technologies for the development of infectious disease vaccines. Nature Reviews Drug Discovery, 1–25.

Hamisi MA, Mohd Asri NA, Mat Yassim AS, Suppian R. 2024. A systematic review on malaria and tuberculosis (TB) vaccine challenges in Sub-Saharan African clinical trials. medRxiv, 2024-02.

Hejran AB, Sarwari A, Hassand MH. 2025. Exploring the expensive therapeutic potential and clinical applications of viruses severe acute respiratory syndrome (SARS)-CoV-2. Life Research 8(1), 2.

Hsieh CL, Leist SR, Miller EH, Zhou L, Powers JM, Tse AL, Wang A, West A, Zweigart MR, Schisler JC, Jangra RK. 2024. Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge. Nature Communications 15(1), 1553.

Huang S, Li Y, Zhang S, Chen Y, Su W, Sanchez DJ, Mai JD, Zhi X, Chen H, Ding X. 2024. A self-assembled graphene oxide adjuvant induces both enhanced humoral and cellular immune responses in influenza vaccine. Journal of Controlled Release 365, 716–728.

Hwang T. 2024. Progress deferred: Lessons from mRNA vaccine development. Institute for Progress Metascience Report (February 20).

Imodoye SO, Adedokun KA, Bello IO. 2024. From complexity to clarity: Unravelling tumor heterogeneity through the lens of tumor microenvironment for innovative cancer therapy. Histochemistry and Cell Biology 161(4), 299–323.

Jamali Y. 2024. Modeling the immune system through agent-based modeling: A mini-review. Immunoregulation 6(1), 3–12.

Jin C, Zhang Y, Li B, Gao T, Wang B, Hua P. 2024. Robust anti-tumor immunity through the integration of targeted lipid nanoparticle-based mRNA nanovaccines with PD-1/PD-L1 blockade. Materials Today Bio 27, 101136.

Kumar A, Middha SK, Menon SV, Paital B, Gokarn S, Nelli M, Rajanikanth RB, Chandra HM, Mugunthan SP, Kantwa SM, Usha T. 2024. Current challenges of vaccination in fish health management. Animals 14(18), 2692.

Lensch V, Johnson JA, Kiessling LL. 2024. Glycoconjugate vaccines: Platforms and adjuvants for directed immunity. Glycobiology 34(11), cwae092.

Liu X, Zhu G. 2025. Circular RNA therapeutics and vaccines. Trends in mRNA Vaccine Research, 161–176.

Lusso P. 2025. mRNA vaccines for HIV‐1. Trends in mRNA Vaccine Research, 259–283.

Mazzocco G, Niemiec I, Myronov A, Skoczylas P, Kaczmarczyk J, Sanecka-Duin A, Gruba K, Krol P, Drwal M, Szczepanik M, Pyrc K. 2021. AI aided design of epitope-based vaccine for the induction of cellular immune responses against SARS-CoV-2. Frontiers in Genetics 12, 602196.

McBride DA, Jones RM, Bottini N, Shah NJ. 2024. The therapeutic potential of immunoengineering for systemic autoimmunity. Nature Reviews Rheumatology 20(4), 203–215.

Morrocchi E, van Haren S, Palma P, Levy O. 2024. Modeling human immune responses to vaccination in vitro. Trends in Immunology.

Nejabat S, Khomartash MS, Mohammadimehr M, Adloo Z, Zanchi FB, Ghorbani M, Nezafat N. 2024. Immunoinformatics approach: Developing a multi-epitope vaccine with novel carriers targeting monkeypox virus. The FASEB Journal 38(24), e70257.

Olawade DB, Teke J, Fapohunda O, Weerasinghe K, Usman SO, Ige AO, David-Olawade AC. 2024. Leveraging artificial intelligence in vaccine development: A narrative review. Journal of Microbiological Methods, 106998.

Panday MK, Agarwal MB, Mehrotra M, Mittal P, Goyal P, Agarwal S, Etana NM. 2025. New developments and challenges in nanomaterial-based vaccine delivery. Exploring Nanomaterial Synthesis, Characterization, and Applications, 379–404.

Pardi N, Krammer F. 2024. mRNA vaccines for infectious diseases—advances, challenges and opportunities. Nature Reviews Drug Discovery, 1–24.

Parvin N, Joo SW, Mandal TK. 2024. Enhancing vaccine efficacy and stability: A review of the utilization of nanoparticles in mRNA vaccines. Biomolecules 14(8), 1036.

Pérez-Saucedo D, Castro-Perea NV, Ruíz-Cruz A, Bustos-Jaimes I, Viveros-Rogel M, Huerta-Hernández L, Moreno-Fierros L. 2025. Design and evaluation of a multi-epitope HIV-1 vaccine based on human parvovirus virus-like particles. Vaccine 45, 126663.

Ponne S, Kumar R, Vanmathi SM, Brilhante RS, Kumar CR. 2024. Reverse engineering protection: A comprehensive survey of reverse vaccinology-based vaccines targeting viral pathogens. Vaccine.

Sharma P, Hoorn D, Aitha A, Breier D, Peer D. 2024. The immunostimulatory nature of mRNA lipid nanoparticles. Advanced Drug Delivery Reviews, 115175.

Shukla R, Vyas K, Khadela A, Vora LK, Khatri DK. 2024. Vaccine safety, efficacy, and ethical considerations. Advanced Vaccination Technologies for Infectious and Chronic Diseases, 311–324.

Tenginakai P, Bhor S, Waasia FZ, Sharma S, Dinesh S. 2025. Comparative proteomic analysis to annotate the structural association of the hypothetical proteins from the conserved domain of P. aeruginosa as novel vaccine candidates. Biotechnology Letters 47(1), 13.

Ugwu OP, Alum EU, Ugwu JN, Eze VH, Ugwu CN, Ogenyi FC, Okon MB. 2024. Harnessing technology for infectious disease response in conflict zones: Challenges, innovations, and policy implications. Medicine 103(28), e38834.

Vaghasia V, Lata KS, Patel S, Das J. 2025. Epitopes mapping for identification of potential cross-reactive peptide against leptospirosis. Journal of Biomolecular Structure and Dynamics 43(1), 20–35.

Vasudevan SS, Kandrikar TY, Sayyed AA, Sridhar S, Prasad A, Khandelwal S, Baniya S, Miguela CA, Gondaliya P. 2024. Personalized vaccines, novel vaccination technologies, and future prospects. Advanced Vaccination Technologies for Infectious and Chronic Diseases, 225–242.

Vidanagamachchi SM, Waidyarathna KM. 2024. Opportunities, challenges and future perspectives of using bioinformatics and artificial intelligence techniques on tropical disease identification using omics data. Frontiers in Digital Health 6, 1471200.

Wang E, Cohen AA, Caldera LF, Keeffe JR, Rorick AV, Aida YM, Gnanapragasam PN, Bjorkman PJ, Chakraborty AK. 2024. Designed mosaic nanoparticles enhance cross-reactive immune responses in mice. bioRxiv.

Wang J, Ding Y, Chong K, Cui M, Cao Z, Tang C, Tian Z, Hu Y, Zhao Y, Jiang S. 2024. Recent advances in lipid nanoparticles and their safety concerns for mRNA delivery. Vaccines 12(10), 1148.

Wang Y, Zhang Z, Luo J, Han X, Wei Y, Wei X. 2021. mRNA vaccine: A potential therapeutic strategy. Molecular Cancer 20(1), 33.

Weerarathna IN, Doelakeh ES, Kiwanuka L, Kumar P, Arora S. 2024. Prophylactic and therapeutic vaccine development: Advancements and challenges. Molecular Biomedicine 5(1), 57.

Xu L, Yang Q, Dong W, Li X, Wang K, Dong S, Zhang X, Yang T, Luo G, Liao X, Gao X. 2025. Meta learning for mutant HLA class I epitope immunogenicity prediction to accelerate cancer clinical immunotherapy. Briefings in Bioinformatics 26(1), bbae625.

Xu Y, Zhu F, Zhou Z, Ma S, Zhang P, Tan C, Luo Y, Qin R, Chen J, Pan P. 2024. A novel mRNA multi-epitope vaccine of Acinetobacter baumannii based on multi-target protein design in immunoinformatic approach. BMC Genomics 25(1), 791.

Yang L, Li S, Hou C, Wang Z, He W, Zhang W. 2025. Recent advances in mRNA-based therapeutics for neurodegenerative diseases and brain tumors. Nanoscale.

Zhao X, Yang VB, Menta AK, Blum J, Wahida A, Subbiah V. 2024. AlphaFold’s predictive revolution in precision oncology. AI in Precision Oncology 1(3), 160–167.